424 related articles for article (PubMed ID: 22010356)
1. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
[TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
Ma HL; Xu YF; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2008 Apr; 354(1-2):217-26. PubMed ID: 18191350
[TBL] [Abstract][Full Text] [Related]
3. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
[TBL] [Abstract][Full Text] [Related]
4. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs.
Zhang C; Qu G; Sun Y; Yang T; Yao Z; Shen W; Shen Z; Ding Q; Zhou H; Ping Q
Eur J Pharm Sci; 2008 Apr; 33(4-5):415-23. PubMed ID: 18337069
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
7. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
8. High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging.
Xiao Y; Lin ZT; Chen Y; Wang H; Deng YL; Le DE; Bin J; Li M; Liao Y; Liu Y; Jiang G; Bin J
Int J Nanomedicine; 2015; 10():1155-72. PubMed ID: 25709439
[TBL] [Abstract][Full Text] [Related]
9. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.
Lee PW; Hsu SH; Wang JJ; Tsai JS; Lin KJ; Wey SP; Chen FR; Lai CH; Yen TC; Sung HW
Biomaterials; 2010 Feb; 31(6):1316-24. PubMed ID: 19959224
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10-NGR9 ultrasmall superparamagnetic iron oxide nanoparticles.
Wu T; Ding X; Su B; Soodeen-Lalloo AK; Zhang L; Shi JY
Clin Transl Oncol; 2018 May; 20(5):599-606. PubMed ID: 28956266
[TBL] [Abstract][Full Text] [Related]
11. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol.
Ruiz A; Hernández Y; Cabal C; González E; Veintemillas-Verdaguer S; Martínez E; Morales MP
Nanoscale; 2013 Dec; 5(23):11400-8. PubMed ID: 23832394
[TBL] [Abstract][Full Text] [Related]
13. Uptake and bioreactivity of charged chitosan-coated superparamagnetic nanoparticles as promising contrast agents for magnetic resonance imaging.
Kania G; Sternak M; Jasztal A; Chlopicki S; Błażejczyk A; Nasulewicz-Goldeman A; Wietrzyk J; Jasiński K; Skórka T; Zapotoczny S; Nowakowska M
Nanomedicine; 2018 Jan; 14(1):131-140. PubMed ID: 28939490
[TBL] [Abstract][Full Text] [Related]
14. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging.
Yuk SH; Oh KS; Cho SH; Lee BS; Kim SY; Kwak BK; Kim K; Kwon IC
Biomacromolecules; 2011 Jun; 12(6):2335-43. PubMed ID: 21506550
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
16. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
17. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
Shan X; Yuan D; Xiong F; Gu N; Wang P
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
[TBL] [Abstract][Full Text] [Related]
18. (Carboxymethyl)chitosan-modified superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of stem cells.
Shi Z; Neoh KG; Kang ET; Shuter B; Wang SC; Poh C; Wang W
ACS Appl Mater Interfaces; 2009 Feb; 1(2):328-35. PubMed ID: 20353220
[TBL] [Abstract][Full Text] [Related]
19. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution.
Wang J; Huang G
Drug Deliv; 2011 Nov; 18(8):631-8. PubMed ID: 22111976
[TBL] [Abstract][Full Text] [Related]
20. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
Martin AR; Thompson RB; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):335-42. PubMed ID: 18800881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]